Drug factory · FDA FEI 3025372239

Zhejiang Huahai Pharmaceutical Technology Co., Ltd.

No.1800, Huifengnan Road, Jiangnan Street, Linhai, Taizhou, China

China: 1

Problems found, fixed voluntarily at FDA's last inspection, Aug 22, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

1 drug inspection on record since 2025: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AripiprazoleMakes it Solco Healthcare U.S., LLC 43547-302, 43547-303, 43547-304 +3
EnalaprilatMakes it Solco Healthcare U.S., LLC 43547-545, 43547-546, 43547-547 +1
EscitalopramMakes it BluePoint Laboratories. 68001-591, 68001-592, 68001-593
GabapentinMakes it Solco Healthcare U.S., LLC 43547-479, 43547-480, 43547-481
Hydrochlorothiazide and LosartanMakes it Solco Healthcare U.S., LLC 43547-423, 43547-424, 43547-425
Hydrochlorothiazide and ValsartanMakes it Solco Healthcare U.S., LLC 43547-311, 43547-312, 43547-313 +2
NebivololMakes it Solco Healthcare U.S., LLC 43547-524, 43547-525, 43547-526 +1
ParoxetineMakes it Solco Healthcare U.S., LLC 43547-347, 43547-348, 43547-349 +1
TadalafilMakes it Solco Healthcare U.S., LLC 43547-047, 43547-049, 43547-050 +1

FDA inspection history

EndedResultProgramProblems noted
Aug 22, 2025Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: manufacture.